TG Therapeutics, Inc.
TGTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $23,383 | $12,672 | -$198,335 | -$348,101 |
| Dep. & Amort. | $280 | $423 | $515 | $494 |
| Deferred Tax | $0 | $0 | $0 | $517 |
| Stock-Based Comp. | $42,541 | $37,933 | $19,185 | $61,274 |
| Change in WC | -$109,297 | -$84,659 | -$1,647 | -$12,216 |
| Other Non-Cash | $2,576 | $2,218 | $4,112 | $2,398 |
| Operating Cash Flow | -$40,517 | -$31,413 | -$176,170 | -$295,634 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$45 | $0 | -$14 | -$401 |
| Net Acquisitions | $0 | $0 | $19,999 | -$69 |
| Inv. Purchases | -$311,891 | -$146,880 | -$107,274 | -$55,531 |
| Inv. Sales/Matur. | $310,900 | $96,229 | $87,275 | $55,600 |
| Other Inv. Act. | $0 | $0 | -$19,999 | $69 |
| Investing Cash Flow | -$1,036 | -$50,651 | -$20,013 | -$332 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $137,262 | $25,000 | -$975 | $40,000 |
| Stock Issued | $0 | $46,296 | $584 | $2,219 |
| Stock Repurch. | -$8,760 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $25 | $1,409 | $0 | -$800 |
| Financing Cash Flow | $128,527 | $72,705 | -$391 | $41,419 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $86,974 | -$9,359 | -$196,574 | -$254,547 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $94,218 | $103,577 | $300,151 | $554,698 |
| End Cash | $181,192 | $94,218 | $103,577 | $300,151 |
| Free Cash Flow | -$40,562 | -$31,413 | -$176,184 | -$296,035 |